Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve 1. Unaudited financial result for the quarter ended on June 30 2025 along with the Limited Review Report of the Auditor pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015.2. Any other business with the permission of Chairman.